The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery. This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
Age range
18 Years – 95 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Berg Balance Scale (BBS) Score
Timeframe: Discharge Assessment (Day 13-14)
Ten Meter Walk Test (10mWT) Time
Timeframe: Discharge Assessment (Day 13-14)
Six Minute Walk Test (6MWT) Distance
Timeframe: Discharge Assessment (Day 13-14)
Inpatient Rehabilitation Facility Patient Assessment Instrument (IRF-PAI) - Admission Quality Indicator (QI) Score: Transfers
Timeframe: Discharge Assessment (Day 13-14)
IRF-PAI - Admission QI Score: Cumulative Ambulation
Timeframe: Discharge Assessment (Day 13-14)
IRF-PAI - Admission QI Score: Cumulative Stairs
Timeframe: Discharge Assessment (Day 13-14)